Literature DB >> 11121975

Changes in patterns of left ventricular hypertrophy after aortic valve replacement for aortic stenosis and regurgitation with St. Jude Medical cardiac valves.

T Murakami1, D Kikugawa, K Endou, Y Fukuhiro, A Ishida, I Morita, H Masaki, H Inada, T Fujiwara.   

Abstract

In this study, we analyzed the extent and pattern of regression of left ventricular (LV) hypertrophy after aortic valve replacement in patients with aortic stenosis (AS) and compared the results with those of another group of patients with aortic regurgitation (AR). Seventy patients who underwent isolated aortic valve replacement were divided into 2 groups. Group 1 was comprised of 29 patients who underwent aortic valve replacement for aortic stenosis, and Group 2 of 41 patients who underwent aortic valve replacement for aortic regurgitation. A third group of 10 healthy subjects served as a healthy control group. Echocardiographic studies were done before the operation and 5 years postoperatively. At follow-up, a significant reduction in the left ventricular mass was found in both groups, but it remained significantly greater than in the healthy control group. The ratio of LV wall thickness to radius (th/r) in Group 1 decreased significantly, and at follow-up it was within the normal value. In Group 2, the th/r ratio increased, and at follow-up it was within the normal value. After aortic valve replacement, the wall thickness remained significantly greater than normal for patients with AS, and the chamber radius remained significantly greater than normal for patients with AR. For these reasons, LV hypertrophy still existed in both groups at postoperative follow-up. The actuarial survival rate was 85.3% at 16 years for Group 1 and 83.4% at 18 years for Group 2. There was no significant difference in the long-term survival rates between the 2 groups. Actuarial freedom from valve-related events was 91.9% at 16 years for Group 1 and 82% at 18 years for Group 2. There was no significant difference in the valve-related event free curves between groups. After 5 years of follow-up, th/r reached normal for both groups, indicating remodeling of the LV geometry after aortic valve replacement.

Entities:  

Mesh:

Year:  2000        PMID: 11121975     DOI: 10.1046/j.1525-1594.2000.06641.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  4 in total

1.  Effect of adjustable passive constraint on the failing left ventricle: a finite-element model study.

Authors:  Choon-Sik Jhun; Jonathan F Wenk; Zhihong Zhang; Samuel T Wall; Kay Sun; Hani N Sabbah; Mark B Ratcliffe; Julius M Guccione
Journal:  Ann Thorac Surg       Date:  2010-01       Impact factor: 4.330

2.  The next revolution: percutaneous aortic valve replacement.

Authors:  Martin B Leon; Eugenia Nikolsky
Journal:  Rambam Maimonides Med J       Date:  2010-10-31

3.  Cholecystokinin Expression in the Development of Myocardial Hypertrophy.

Authors:  Zhongshu Han; Sheng Bi; Yongsheng Xu; Xiaoying Dong; Lixia Mei; Hailong Lin; Xueqi Li
Journal:  Scanning       Date:  2021-08-21       Impact factor: 1.932

4.  Degenerative valve disease and bioprostheses: risk assessment, predictive diagnosis, personalised treatments.

Authors:  Kristina Yeghiazaryan; Dirk Skowasch; Gerhard Bauriedel; Hans H Schild; Olga Golubnitschaja
Journal:  EPMA J       Date:  2011-04-03       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.